PT3010488T - Lípidos estereoespecíficos para a terapia locorregional com sistemas nanotransportadores sensíveis a estímulos de circulação a longo prazo - Google Patents

Lípidos estereoespecíficos para a terapia locorregional com sistemas nanotransportadores sensíveis a estímulos de circulação a longo prazo

Info

Publication number
PT3010488T
PT3010488T PT147309322T PT14730932T PT3010488T PT 3010488 T PT3010488 T PT 3010488T PT 147309322 T PT147309322 T PT 147309322T PT 14730932 T PT14730932 T PT 14730932T PT 3010488 T PT3010488 T PT 3010488T
Authority
PT
Portugal
Prior art keywords
stimuli
long
sensitive nanocarrier
term circulating
nanocarrier systems
Prior art date
Application number
PT147309322T
Other languages
English (en)
Original Assignee
THERMOSOME GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THERMOSOME GmbH filed Critical THERMOSOME GmbH
Publication of PT3010488T publication Critical patent/PT3010488T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • C07F9/106Adducts, complexes, salts of phosphatides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
PT147309322T 2013-06-18 2014-06-18 Lípidos estereoespecíficos para a terapia locorregional com sistemas nanotransportadores sensíveis a estímulos de circulação a longo prazo PT3010488T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13172469 2013-06-18

Publications (1)

Publication Number Publication Date
PT3010488T true PT3010488T (pt) 2021-08-03

Family

ID=48628349

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147309322T PT3010488T (pt) 2013-06-18 2014-06-18 Lípidos estereoespecíficos para a terapia locorregional com sistemas nanotransportadores sensíveis a estímulos de circulação a longo prazo

Country Status (18)

Country Link
US (1) US10251838B2 (pt)
EP (1) EP3010488B1 (pt)
JP (1) JP6501765B2 (pt)
KR (1) KR102242183B1 (pt)
CN (1) CN105431139B (pt)
AU (1) AU2014283264C1 (pt)
BR (1) BR112015031495B1 (pt)
CA (1) CA2922627C (pt)
DK (1) DK3010488T3 (pt)
EA (1) EA033891B1 (pt)
ES (1) ES2881699T3 (pt)
HK (1) HK1217647A1 (pt)
HU (1) HUE054713T2 (pt)
IL (1) IL243212B (pt)
MX (1) MX2015017505A (pt)
PL (1) PL3010488T3 (pt)
PT (1) PT3010488T (pt)
WO (1) WO2014202680A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018510859A (ja) * 2015-03-17 2018-04-19 レオン−ナノドラッグズ ゲーエムベーハー 安定化されたボロン酸化合物を含むナノ粒子
CN116033906A (zh) 2020-07-07 2023-04-28 特默佐梅有限公司 脂质体制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI874742A (fi) * 1987-10-28 1989-04-29 K & V Licencing Oy Foerfarande foer framstaellning av liposomer.
ES2202576T3 (es) * 1996-02-16 2004-04-01 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Fosfatidil-oligogliceroles.
US6177282B1 (en) * 1997-08-12 2001-01-23 Mcintyre John A. Antigens embedded in thermoplastic
US6200598B1 (en) 1998-06-18 2001-03-13 Duke University Temperature-sensitive liposomal formulation
DE10107165A1 (de) * 2001-02-15 2002-08-29 Max Planck Gesellschaft Thermolabiles Liposom mit geregelter Freigabetemperatur
DE10242367A1 (de) 2002-09-12 2004-03-18 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Thermolabiles Liposom mit geregelter Freigabetemperatur
KR20100092016A (ko) * 2007-11-30 2010-08-19 엔도 파마슈티컬즈, 솔루션스 아이엔씨. 방광암 치료용 발루비신을 갖는 방광내 투약 조성물
JP5382567B2 (ja) 2008-05-02 2014-01-08 公立大学法人大阪府立大学 温度感受性リポソーム
EP2638896A1 (en) * 2012-03-14 2013-09-18 Bioneer A/S Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood

Also Published As

Publication number Publication date
EP3010488A1 (de) 2016-04-27
JP2016523242A (ja) 2016-08-08
IL243212B (en) 2020-01-30
ES2881699T3 (es) 2021-11-30
CN105431139A (zh) 2016-03-23
CA2922627A1 (en) 2014-12-24
CN105431139B (zh) 2019-10-01
DK3010488T3 (da) 2021-05-31
IL243212A0 (en) 2016-02-29
AU2014283264B2 (en) 2019-05-02
CA2922627C (en) 2022-03-08
BR112015031495A2 (pt) 2017-07-25
EP3010488B1 (de) 2021-05-05
EA201690029A1 (ru) 2016-05-31
BR112015031495B1 (pt) 2023-04-11
AU2014283264C1 (en) 2019-08-29
JP6501765B2 (ja) 2019-04-17
US10251838B2 (en) 2019-04-09
HUE054713T2 (hu) 2021-09-28
US20160136092A1 (en) 2016-05-19
EA033891B1 (ru) 2019-12-05
KR20160026984A (ko) 2016-03-09
HK1217647A1 (zh) 2017-01-20
KR102242183B1 (ko) 2021-04-20
PL3010488T3 (pl) 2021-11-15
WO2014202680A1 (de) 2014-12-24
MX2015017505A (es) 2016-08-05
AU2014283264A1 (en) 2016-02-04

Similar Documents

Publication Publication Date Title
IL279408B (en) An infusion system to prevent the wrong referral of a large number of drugs
EP2968043A4 (en) Patient repositioning system
ZA201507315B (en) Selective gene therapy expression system
EP2968749A4 (en) DOUBLE ACTION PERFUSION SYSTEM
GB2513596B (en) Image-guided radiotherapy
SG11201605156WA (en) Ct systems and methods
GB201605242D0 (en) Catheter
ZA201507755B (en) Tumor-selective combination therapy
GB201321078D0 (en) Syringe assemblies
EP2987531A4 (en) PARTICULATE THERAPY SYSTEM
GB201310755D0 (en) Therapy
HK1215152A1 (zh) 具有受控柔性的輸送導管
IL245618A0 (en) Inhalation medicine
TWI562796B (en) Catheter system
HK1222139A1 (zh) 可拆開導管
IL243212B (en) Stereospecific lipids for local treatment with a touch-sensitive and long-lasting nano-carrier system
HK1211243A1 (en) An inhalable medicament
IL233698B (en) A catheter of multiple shapes
GB201313356D0 (en) Therapeutic Intervention
GB201518731D0 (en) Tumour Therapy
EP2951661A4 (en) CONTROLLED HEAT DELIVERY
GB201308365D0 (en) Tumour therapy
GB201316687D0 (en) Computer controlled inhaler system
GB201320786D0 (en) Medicament
GB201304807D0 (en) Catheter